FMD Press Releases
“Proclamation of Fibromuscular Dysplasia Month in Michigan.” Office of the Governor, March 2015.
“Racing Toward an Answer – UM research moves closer to demystifying fibromuscular dysplasia.” Colleagues in Care, Spring 2015.
“'Thought I was going to die': Hidden heart disease a stroke risk for younger women.” Today: Health and Wellness, February 18, 2015.
“Resolution to Designate March 2015 as Fibromuscular Dysplasia (FMD) Awareness Month in Pennsylvania.” Pennsylvania House of Representatives, March 20, 2015.
PHS Press Releases:
“Lessons learned: Healthier outlook four years after school-based program” University of Michigan Health System News. October 22, 2015.
MAQI Press Releases:
Anticoagulation Toolkit; Voted one of the best medical app released of 2015; Selected by iMedicalApps as one of the best medical apps released in April. The app was described as “stunning in its overall design and utility” and a “well-designed, well-referenced medical app”
Anticoagulation Toolkit; Voted editors pick for medical app released of 2015; Selected as an Editor’s pick by MDLinx which noted that “There are many apps available to help you do these calculations, but few are so well designed or so effortless to use.”
The goal of Michigan Clinical Outcomes Research and Reporting Program (MCORRP) is to improve the quality of cardiovascular care at the University of Michigan Health System, in the state of Michigan, and throughout the United States and world. This will be accomplished by studying common cardiovascular conditions and procedures among large populations; developing modern mathematical tools to assess risk and outcomes; promoting evidence-based care models which incorporate best science into care itself by targeting physicians, nurses, and patients.
MCORRP will extend its reach by presenting and publishing scientific results at regional, national and international meetings and in peer-reviewed publications as well as by partnering with regional and national organizations for win-win solutions to overcoming barriers to providing quality cardiovascular care. Finally, MCORRP is committed to creating a vibrant, rigorous, diverse, and collegial research environment which promotes the investigative development of students, house officers, fellows, and junior faculty.